본문 바로가기
KERD
논문KCI 등재

Scalable production of tissue-like vascularized liver organoids from human PSCs

0

조회

0

다운로드

1

인용

0

참고문헌

주제분류생화학

초록

The lack of physiological parity between 2D cell culture and in vivo culture has led to the development of more organotypic models, such as organoids. Organoid models have been developed for a number of tissues, including the liver. Current organoid protocols are characterized by a reliance on extracellular matrices (ECMs), patterning in 2D culture, costly growth factors and a lack of cellular diversity, structure, and organization. Current hepatic organoid models are generally simplistic and composed of hepatocytes or cholangiocytes, rendering them less physiologically relevant compared to native tissue. We have developed an approach that does not require 2D patterning, is ECM independent, and employs small molecules to mimic embryonic liver development that produces large quantities of liver-like organoids. Using single-cell RNA sequencing and immunofluorescence, we demonstrate a liver-like cellular repertoire, a higher order cellular complexity, presenting with vascular luminal structures, and a population of resident macrophages: Kupffer cells. The organoids exhibit key liver functions, including drug metabolism, serum protein production, urea synthesis and coagulation factor production, with preserved post-translational modifications such as N-glycosylation and functionality. The organoids can be transplanted and maintained long term in mice producing human albumin. The organoids exhibit a complex cellular repertoire reflective of the organ and have de novo vascularization and liver-like function. These characteristics are a prerequisite for many applications from cellular therapy, tissue engineering, drug toxicity assessment, and disease modeling to basic developmental biology.

Abstract

The lack of physiological parity between 2D cell culture and in vivo culture has led to the development of more organotypic models, such as organoids. Organoid models have been developed for a number of tissues, including the liver. Current organoid protocols are characterized by a reliance on extracellular matrices (ECMs), patterning in 2D culture, costly growth factors and a lack of cellular diversity, structure, and organization. Current hepatic organoid models are generally simplistic and composed of hepatocytes or cholangiocytes, rendering them less physiologically relevant compared to native tissue. We have developed an approach that does not require 2D patterning, is ECM independent, and employs small molecules to mimic embryonic liver development that produces large quantities of liver-like organoids. Using single-cell RNA sequencing and immunofluorescence, we demonstrate a liver-like cellular repertoire, a higher order cellular complexity, presenting with vascular luminal structures, and a population of resident macrophages: Kupffer cells. The organoids exhibit key liver functions, including drug metabolism, serum protein production, urea synthesis and coagulation factor production, with preserved post-translational modifications such as N-glycosylation and functionality. The organoids can be transplanted and maintained long term in mice producing human albumin. The organoids exhibit a complex cellular repertoire reflective of the organ and have de novo vascularization and liver-like function. These characteristics are a prerequisite for many applications from cellular therapy, tissue engineering, drug toxicity assessment, and disease modeling to basic developmental biology.

참고문헌 (81)

  1. Trefts, E., "The liver", Curr. Biol, 27, pp.R1147~R1151 (2017)
  2. Yin, X., "Engineering Stem Cell Organoids", Cell Stem Cell, 18, pp.25~38 (2016)
  3. Ouchi, R., "Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids", Cell Metab, 30, pp.374~384 (2019)
  4. Ström, S., "Derivation of 30human embryonic stem cell lines-improving the quality", Vitr. Cell. Dev. Biol. Anim, 46, pp.337~344 (2010)
  5. Mathapati, S., "Small-Molecule-Directed Hepatocyte-Like Cell Differentiation of Human Pluripotent Stem Cells", Curr. Protoc. Stem Cell Biol, 38, pp.1G.6.1~1G.6.18 (2016)
  6. Siller, R., "Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells", Stem Cell Rep, 4, pp.939~952 (2015)
  7. Siller, R., "Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cell lines", Sci. Rep, 6, pp.37178~ (2016)
  8. Siller, R., "Rapid Screening of the Endodermal Differentiation Potential of Human Pluripotent Stem Cells", Curr. Protoc. Stem Cell Biol, 43, pp.1G.7.1~1G.7.23 (2017)
  9. Kempf, H., "Bulk cell density and Wnt", TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells, 2016, pp.7, 13602~
  10. Lunova, M., "Light-induced modulation of the mitochondrial respiratory chain activity : possibilities and limitations", Cell Mol. Life Sci, 77, pp.2815~2838 (2020)
  11. de Chaumont, F., "Icy : an open bioimage informatics platform for extended reproducible research", Nat. Methods, 9, pp.690~696 (2012)
  12. Karinen, R., "Determination of heroin and its main metabolites in small sample volumes of whole blood and brain tissue by reversed-phase liquid chromatography-tandem mass spectrometry", J. Anal. Toxicol, 33, pp.345~350 (2009)
  13. Falcon, S., "Using GOstats to test gene lists for GO term association", Bioinformatics, 23, pp.257~258 (2007)
  14. Xiang, Y., "hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids", Cell Stem Cell, 24, pp.487~497 (2019)
  15. Butler, A., "Integrating single-cell transcriptomic data across different conditions, technologies, and species", Nat. Biotechnol, 36, pp.411~420 (2018)
  16. Cakir, B., "Engineering of human brain organoids with a functional vascularlike system", Nat. Methods, 16, pp.1169~1175 (2019)
  17. Aizarani, N., "A human liver cell atlas reveals heterogeneity and epithelial progenitors", Nature, 572, pp.199~204 (2019)
  18. Subramanian, A., "Gene set enrichment analysis : a knowledge-based approach for interpreting genome-wide expression profiles", Proc. Natl Acad. Sci. USA, 102, pp.15545~15550 (2005)
  19. Xie, B., "A two-step lineage reprogramming strategy to generate functionally competent human hepatocytes from fibroblasts", Cell Res, 29, pp.696~710 (2019)
  20. Koui, Y., "An In Vitro Human Liver Model by iPSC-Derived Parenchymal and Non-parenchymal Cells", Stem Cell Rep, 9, pp.490~498 (2017)
  21. Oikawa, T., "Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells", Nat. Commun, 6, pp.8070~ (2015)
  22. Martin-Mateos, R., "Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis", Cell Mol. Gastroenterol. Hepatol, 7, pp.197~209 (2019)
  23. Marcu, R., "Human Organ-Specific Endothelial Cell Heterogeneity", iScience, 4, pp.20~35 (2018)
  24. Trapnell, C., "TopHat: discovering splice junctions with RNA-Seq", Bioinformatics, 25, pp.1105~1111 (2009)
  25. Anders, S., "HTSeq-a Python framework to work with highthroughput sequencing data", Bioinformatics, 31, pp.166~169 (2015)
  26. Risso, D., "Normalization of RNA-seq data using factor analysis of control genes or samples", Nat. Biotechnol, 32, pp.896~902 (2014)
  27. Brosch, M., "Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control", Nat. Commun, 9, pp.4150~ (2018)
  28. Zhu, F., "A modified method for implantation of pluripotent stem cells under the rodent kidney capsule", Stem Cells Dev, 23, pp.2119~2125 (2014)
  29. Shultz, L. D., "Subcapsular transplantation of tissue in the kidney", Cold Spring Harb. Protoc, 2014, pp.737~740 (2014)
  30. Sullivan, G. J., "Generation of functional human hepatic endoderm from human induced pluripotent stem cells", Hepatology, 51, pp.329~335 (2010)
  31. Asahina, K., "Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver", Hepatology, 53, pp.983~995 (2011)
  32. Li, Y., "Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury", Proc. Natl Acad. Sci. USA, 110, pp.2324~2329 (2013)
  33. Matsumoto, K., "Liver organogenesis promoted by endothelial cells prior to vascular function", Science, 294, pp.559~563 (2001)
  34. Schmidt, C., "Scatter factor", hepatocyte growth factor is essential for liver development, 1995, pp.373, 699~702
  35. Apte, U., "Activation of Wnt", beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice, 2006, pp.44, 992~1002
  36. Cheng, H. C., "Zonation of cholesterol and glycerolipid synthesis in regenerating rat livers", Hepatol, 17, pp.280~286 (1993)
  37. Ben-Moshe, S., "Spatial heterogeneity in the mammalian liver", Nat. Rev. Gastroenterol. Hepatol, 16, pp.395~410 (2019)
  38. Moorman, A. F., "Localization of ammonia-metabolizing enzymes in human liver : ontogenesis of heterogeneity", Hepatology, 9, pp.367~372 (1989)
  39. Bissell, D. M., "Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation", J. Clin. Invest, 96, pp.447~455 (1995)
  40. Samarasinghe, D. A., "Role of oxidative stress in hypoxiareoxygenation injury to cultured rat hepatic sinusoidal endothelial cells", Hepatology, 31, pp.160~165 (2000)
  41. MacParland, S. A., "Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations", Nat. Commun, 9, pp.4383~ (2018)
  42. Liang, Y., "Temporal Analyses of Postnatal Liver Development and Maturation by Single Cell Transcriptomics", bioRxiv, 2021.2007.2014.451852, ~ (2021)
  43. Jensen, K. J., "Hepatic Nervous System and Neurobiology of the Liver", Comprehensive Physiol, 3, pp.655~665 (2013)
  44. Rosenquist, G. C., "Epiblast origin and early migration of neural crest cells in the chick embryo", Dev. Biol, 87, pp.201~211 (1981)
  45. Prasad, M. S., "Blastula stage specification of avian neural crest", Dev. Biol, 458, pp.64~74 (2020)
  46. Poyck, P. P. C., "Expression of Glutamine Synthetase and Carbamoylphosphate Synthetase I in a Bioartificial Liver : Markers for the Development of Zonation in vitro", Cells Tissues Organs, 188, pp.259~269 (2008)
  47. Baxter, M., "Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes", J. Hepatol, 62, pp.581~589 (2015)
  48. Peters, D. T., "Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells", Development, 143, pp.1475~1481 (2016)
  49. Li, Y., "Structure of the conserved cytoplasmic C-terminal domain of occludin : identification of the ZO-1 binding surface", J. Mol. Biol, 352, pp.151~164 (2005)
  50. Orbán, E., "Different expression of occludin and ZO-1 in primary and metastatic liver tumors", Pathol. Oncol. Res, 14, pp.299~306 (2008)
  51. Desmet, V. J., "Cytokeratins for probing cell lineage relationships in developing liver", Hepatology, 12, pp.1249~1251 (1990)
  52. Kasprzak, A., "Mucins : the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis", Int. J. Mol. Sci, 20, pp.1288~ (2019)
  53. Wimmer, R. A., "Human blood vessel organoids as a model of diabetic vasculopathy", Nature, 565, pp.505~510 (2019)
  54. Strauss, O., "Immunofluorescence identifies distinct subsets of endothelial cells in the human liver", Sci. Rep, 7, pp.44356~ (2017)
  55. Kristine, S. K., "Liver Sinusoidal Endothelial", Cells, 5 (2015)
  56. Hollestelle, M. J., "Tissue distribution of factor VIII gene expression in vivo-a closer look", Thromb. Haemost, 86, pp.855~861 (2001)
  57. Pandey, E., "Prominent Receptors of Liver Sinusoidal Endothelial Cells in Liver Homeostasis and Disease", Front. Physiol, 11, pp.873~ (2020)
  58. Gage, B. K., "Generation of Functional Liver Sinusoidal Endothelial Cells from Human Pluripotent Stem-Cell-Derived Venous Angioblasts", Cell Stem Cell, 27, pp.254~269 (2020)
  59. Ginhoux, F., "Monocytes and macrophages : developmental pathways and tissue homeostasis", Nat. Rev. Immunol, 14, pp.392~404 (2014)
  60. Hoeffel, G., "C-Myb(+)erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages", Immunity, 42, pp.665~678 (2015)
  61. Beljaars, L., "Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans", Front Immunol, 5, pp.430~ (2014)
  62. Wilson, N. K., "Combinatorial Transcriptional Control In Blood Stem", Progenitor Cells : Genome-wide Analysis of Ten Major Transcriptional Regulators, 2010, pp.7, 532~544
  63. Geerts, A., "On the origin of stellate cells: mesodermal, endodermal or neuroectodermal?", J. Hepatol, 40, pp.331~334 (2004)
  64. Ogu, C. C., "Drug interactions due to cytochrome P450", Proc. (Bayl. Univ. Med Cent.), 13, pp.421~423 (2000)
  65. Cerny, M. A., "Prevalence of Non–Cytochrome P450–Mediated Metabolism in Food and Drug Administration–Approved Oral and Intravenous Drugs: 2006–2015", Drug Metab. Disposition, 44, pp.1246~1252 (2016)
  66. Wang, D., "Human carboxylesterases : a comprehensive review", Acta Pharm. Sin. B, 8, pp.699~712 (2018)
  67. Lewis, S. L., "Clinical Companion to Medical-Surgical Nursing: Assessment and Management of Clinical Problems" (2013), Elsevier
  68. Tigges, U., "FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages", Development, 135, pp.523~532 (2008)
  69. Franko, A., "Identification of the Secreted Proteins Originated from Primary Human Hepatocytes and HepG2 Cells", Nutrients, 11, pp.1795~ (2019)
  70. Lilkova, E., "Molecular modeling of the effects of glycosylation on the structure and dynamics of human interferon-gamma", J. Mol. Model, 25, pp.127~ (2019)
  71. Stelzl, T., "Glycans in the intestinal peptide transporter PEPT1 contribute to function and protect from proteolysis", Am. J. Physiol. Gastrointest. Liver Physiol, 312, pp.G580~g591 (2017)
  72. Águila, S., "N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function", Int. J. Mol. Sci, 22, pp.516~ (2021)
  73. Dhar, A., "Thrombin and factor Xa link the coagulation system with liver fibrosis", BMC Gastroenterol, 18, pp.60~ (2018)
  74. Schneeberger, K., "Large-Scale Production of LGR5-Positive Bipotential Human Liver Stem Cells", Hepatology, 72, pp.257~270 (2020)
  75. Takebe, T., "Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells", Cell Rep, 21, pp.2661~2670 (2017)
  76. Dhawan, A., "Hepatocyte transplantation for liver-based metabolic disorders", J. Inherit. Metab. Dis, 29, pp.431~435 (2006)
  77. Halloin, C., "Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture", Stem Cell Rep, 13, pp.775~ (2019)
  78. Ackermann, M., "Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections", Nat. Commun, 9, pp.5088~ (2018)
  79. Wendon, J., "EASL Clinical Practical Guidelines on the management of acute(fulminant)liver failure", J. Hepatol, 66, pp.1047~1081 (2017)
  80. Bernal, W., "Outcome after wait-listing for emergency liver transplantation in acute liver failure : A single centre experience", J. Hepatol, 50, pp.306~313 (2009)
  81. Germani, G., "Liver transplantation for acute liver failure in Europe : Outcomes over 20 years from the ELTR database", J. Hepatol, 57, pp.288~296 (2012)

관련 논문AI추천

이 간행물의 다른 논문 (225건)